#United States #Veeva Systems #Pleasanton #COVID-19 #Gilead Sciences

Gilead Sciences Selects Veeva Vault CRM

In an exciting development for the biopharmaceutical industry, Gilead Sciences has officially chosen Veeva Systems, a pioneer in cloud solutions for the life sciences sector, to implement the Veeva Vault CRM platform. This decision underscores Gilead's commitment to expanding its long-standing partnership with Veeva, enhancing its digital transformation towards more effective commercial practices.

Veeva Systems, known for its innovative cloud-based solutions, announced this decision with pride. Its CEO, Peter Gassner, expressed his excitement regarding this partnership, stating, “Gilead is a leader in developing transformative therapies, particularly in areas such as viral diseases and oncology. We are honored to be their strategic partner and to extend our collaboration through Vault CRM.”

Anna Åsberg, Gilead's Global CIO, conveyed her enthusiasm about the move to Vault CRM, which she believes will elevate their commercial operations. “We are deeply committed to advancing medicine, and the potential of Veeva AI aligns perfectly with our vision,” she said. The implementation of Vault CRM is viewed as a pivotal step towards leveraging advanced technologies to propel Gilead's marketing and commercial activities to new heights.

The Vault CRM Suite encompasses a robust set of applications designed to support commercial operations. One of its key features, Veeva AI for Vault CRM, provides multiple AI agents focusing on pre-call planning, compliance with free text, and voice control capabilities. This advanced technology aims to enhance both efficiency and effectiveness in commercial activities, offering pharmaceutical representatives tools to optimize their interactions with healthcare professionals.

About Veeva Systems

Veeva Systems specializes in providing cloud services tailored for the life sciences industry. With over 1,500 clients ranging from the largest biopharmaceutical companies to emerging biotech firms, Veeva is committed to innovation and client success. The company emphasizes a balance among all its stakeholders, including shareholders, employees, and the industries served, operating as a Public Benefit Corporation. For more information about Veeva, visit their website at www.veeva.com/jp/.

About Gilead Sciences

Gilead Sciences has dedicated over 35 years to pursuing medical innovations that promote a healthier world. Based in Foster City, California, and operating in more than 35 countries, Gilead is recognized for its groundbreaking work in developing innovative therapies for life-threatening diseases, including HIV, viral hepatitis, and COVID-19. Their focus on addressing challenging issues in healthcare positions them as a vital player in the biotechnology sector.

In conclusion, Gilead's decision to adopt Veeva Vault CRM sets the stage for enhanced operational capabilities and represents a significant step in their ongoing pursuit of medical advancements. As both companies continue their journey together, the life sciences community eagerly awaits the positive impacts of this collaboration on both patient outcomes and the broader healthcare landscape.